Drug:
Reaction: ILLNESS
20250101 - 20251231
No. 101 - 200
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
101 | 25136818 |
GB |
24 | 2 |
Illness, Diarrhoea, |
||||
TIRZEPATIDE, |
||||
102 | 25136996 |
GB |
2 | |
Illness, Haemorrhage, |
||||
TIRZEPATIDE, |
||||
103 | 25137032 |
US |
2 | |
Myocardial infarction, Thyroid disorder, Hypertension, Illness, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, SEMAGLUTIDE, MAGNESIUM, |
||||
104 | 25137094 |
US |
76 | 2 |
Nasopharyngitis, Illness, |
||||
LENALIDOMIDE, |
||||
105 | 25126265 |
US |
31 | 2 |
Rheumatoid arthritis, Illness, Drug ineffective, |
||||
CERTOLIZUMAB PEGOL, |
||||
106 | 25126287 |
US |
1 | |
Death, Pneumonia, Illness, Diabetes mellitus, Amputee, |
||||
PANCRELIPASE, |
||||
107 | 25126523 |
US |
||
Illness, Infection, Pulmonary thrombosis, Thrombosis, Pericardial effusion, Intra-abdominal fluid collection, |
||||
ECULIZUMAB, |
||||
108 | 25126542 |
US |
66 | 1 |
Illness, |
||||
ADAGRASIB, |
||||
109 | 25126602 |
US |
54 | 2 |
Illness, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
110 | 25126720 |
JP |
||
Illness, Drug ineffective, |
||||
DARBEPOETIN ALFA, |
||||
111 | 25126850 |
US |
60 | 2 |
Injection site pain, Illness, |
||||
BIMEKIZUMAB, |
||||
112 | 25126915 |
US |
36 | 2 |
Illness, |
||||
BIMEKIZUMAB, |
||||
113 | 25126923 |
US |
28 | 1 |
Psoriasis, Illness, Intentional dose omission, |
||||
BIMEKIZUMAB, |
||||
114 | 25126991 |
US |
1 | |
Illness, Diarrhoea, Psoriasis, |
||||
BIMEKIZUMAB, |
||||
115 | 25127006 |
US |
2 | |
Illness, |
||||
BIMEKIZUMAB, |
||||
116 | 25127072 |
US |
1 | |
Illness, |
||||
BIMEKIZUMAB, |
||||
117 | 25127076 |
US |
1 | |
Fatigue, Lethargy, Asthenia, Illness, Depressed mood, |
||||
BIMEKIZUMAB, |
||||
118 | 25127095 |
US |
36 | 1 |
Respiratory tract infection, Illness, Cough, Viral infection, Mouth ulceration, |
||||
BIMEKIZUMAB, |
||||
119 | 25127100 |
US |
2 | |
Illness, |
||||
BIMEKIZUMAB, |
||||
120 | 25127248 |
US |
2 | |
Nasopharyngitis, Illness, |
||||
121 | 25127275 |
US |
1 | |
Illness, Inability to afford medication, Therapy cessation, |
||||
ROTIGOTINE, |
||||
122 | 25127308 |
BR |
7 | 2 |
Haematoma, Foreign body reaction, Illness, Injection site swelling, Injection site abscess, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
123 | 25127317 |
US |
42 | 1 |
Illness, Sleep disorder, |
||||
TIRZEPATIDE, |
||||
124 | 25127470 |
GB |
86 | 2 |
Illness, |
||||
NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), |
||||
125 | 25127521 |
CA |
2 | |
Caesarean section, Uterine haemorrhage, Dysstasia, Urticaria, Somnolence, Illness, Maternal exposure during pregnancy, Intentional dose omission, Drug ineffective, Maternal exposure during breast feeding, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
126 | 25127525 |
CA |
62 | |
Malaise, Wheezing, Pulmonary function test abnormal, Lung adenocarcinoma stage IV, Seizure, Pneumothorax, Exercise tolerance decreased, Drug dependence, Loss of personal independence in daily activities, Full blood count abnormal, Dyspnoea, Chronic obstructive pulmonary disease, Chest discomfort, Bronchitis, Asthma, Therapeutic product effect incomplete, Bone pain, Craniotomy, Gait disturbance, Heart rate increased, Illness, Joint swelling, Metastases to central nervous system, Sleep disorder due to a general medical condition, Steroid dependence, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, BUDESONIDE, BUDESONIDE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, RISEDRONATE SODIUM, ALBUTEROL SULFATE, ERGOCALCIFEROL, ERGOCALCIFEROL, |
||||
127 | 25127570 |
US |
63 | 2 |
Illness, Dyspnoea, Otorrhoea, Nausea, Respiratory tract congestion, Product dose omission issue, |
||||
MEPOLIZUMAB, LEVOTHYROXINE, AMLODIPINE BESYLATE, FAMOTIDINE, SEMAGLUTIDE, MONTELUKAST, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ALBUTEROL SULFATE, ALBUTEROL, CYCLOBENZAPRINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ZOLPIDEM TARTRATE, PREDNISONE, MECLIZINE HCL 12.5 MG, MECLIZINE, MECLIZINE HYDROCHLORIDE, MECLIZINE HCL 25MG, MECLIZINE HCL 12.5MG, BUPROPION HYDROCHLORIDE, BUPROPION, AMOXICILLIN, |
||||
128 | 25127591 |
US |
2 | |
Illness, Vomiting, Nausea, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, |
||||
129 | 25127654 |
GB |
67 | 2 |
Feeding disorder, Nasopharyngitis, Illness, Vertigo, Electric shock sensation, Malaise, Vomiting, Diarrhoea, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, AMLODIPINE, CALCIUM, LEVOTHYROXINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
130 | 25127775 |
US |
||
Cerebrovascular accident, Illness, |
||||
DAPAGLIFLOZIN, |
||||
131 | 25127887 |
US |
85 | 2 |
Illness, Cough, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
132 | 25128278 |
GB |
2 | |
Illness, Product dose omission issue, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
133 | 25128369 |
US |
41 | 2 |
Illness, Dermatitis atopic, |
||||
TRALOKINUMAB-LDRM, |
||||
134 | 25128937 |
2 | ||
Drug ineffective, Pain, Therapy interrupted, Infection, Illness, |
||||
ETANERCEPT, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CALCIUM CARBONATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
135 | 25128987 |
US |
49 | 2 |
Illness, Respiratory syncytial virus infection, Gastroenteritis viral, |
||||
DUPILUMAB, DUPILUMAB, |
||||
136 | 25128991 |
US |
63 | 2 |
Illness, Dysphonia, |
||||
DUPILUMAB, DUPILUMAB, EZETIMIBE, CETIRIZINE HCL, CETIRIZINE, PRAVASTATIN SODIUM, ALLOPURINOL, METHOCARBAMOL, METHOCARBAMOL TABLETS, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, MAGNESIUM, ERGOCALCIFEROL, CETIRIZINE HYDROCHLORIDE, FAMOTIDINE, MONTELUKAST SODIUM, |
||||
137 | 25128999 |
US |
2 | |
Nasopharyngitis, Illness, Viral infection, Cough, Secretion discharge, Condition aggravated, |
||||
DUPILUMAB, |
||||
138 | 25129012 |
US |
70 | 1 |
Illness, Wound, Furuncle, |
||||
INSULIN GLARGINE, |
||||
139 | 25129057 |
US |
||
Illness, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
140 | 25129451 |
CA |
74 | 2 |
Illness, Influenza like illness, Oropharyngeal pain, Skin cancer, Infection, |
||||
ETANERCEPT, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BISOPROLOL FUMARATE, DEXLANSOPRAZOLE, EZETIMIBE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ROSUVASTATIN CALCIUM, |
||||
141 | 25129505 |
US |
76 | 2 |
Illness, Pyrexia, |
||||
TOFACITINIB, UPADACITINIB, |
||||
142 | 25129712 |
IE |
48 | 1 |
Lower respiratory tract infection, Diarrhoea, Illness, Malaise, Inappropriate schedule of product administration, |
||||
SECUKINUMAB, SECUKINUMAB, |
||||
143 | 25129761 |
US |
77 | 2 |
Nasopharyngitis, Illness, |
||||
TOFACITINIB, |
||||
144 | 25129763 |
US |
60 | 2 |
Illness, |
||||
TOFACITINIB, |
||||
145 | 25129863 |
US |
85 | 2 |
Drug intolerance, Illness, Blood test abnormal, |
||||
AVAPRITINIB, AVAPRITINIB, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, CLONAZEPAM, |
||||
146 | 25129889 |
CO |
37 | 2 |
Chronic myeloid leukaemia recurrent, Leukocytosis, White blood cell count decreased, Splenomegaly, Staphylococcal infection, Weight decreased, Decreased immune responsiveness, Asthenia, Myalgia, Chest pain, Product supply issue, Product dose omission issue, Inappropriate schedule of product administration, Ill-defined disorder, Peripheral swelling, Skin discolouration, Dizziness, Malaise, Fatigue, Abdominal distension, Illness, |
||||
NILOTINIB, NILOTINIB, NILOTINIB, NILOTINIB, NILOTINIB, NILOTINIB, NILOTINIB, ALLOPURINOL, CEPHALEXIN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
147 | 25129937 |
US |
2 | |
Adrenal insufficiency, Presyncope, Illness, Flushing, Influenza like illness, Nausea, Pain, Arthralgia, Headache, Oropharyngeal pain, Body temperature abnormal, |
||||
OFATUMUMAB, |
||||
148 | 25129965 |
US |
74 | 1 |
Illness, Diarrhoea, |
||||
NINTEDANIB, NINTEDANIB, |
||||
149 | 25130064 |
US |
66 | 2 |
Illness, |
||||
AXICABTAGENE CILOLEUCEL, |
||||
150 | 25130625 |
BR |
66 | 1 |
Chronic coronary syndrome, Cellulitis, Blood creatine phosphokinase increased, Eczema, Coronary artery disease, Neoplasm, Dyslipidaemia, Urticaria chronic, Blood cholesterol abnormal, Illness, Sciatica, Back pain, Feeling abnormal, |
||||
RANIBIZUMAB, SIMVASTATIN, SIMVASTATIN, PAZOPANIB HYDROCHLORIDE, INCLISIRAN, INCLISIRAN, INCLISIRAN, |
||||
151 | 25130777 |
US |
||
Illness, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
152 | 25130918 |
US |
1 | |
Muscle atrophy, Illness, |
||||
ADALIMUMAB, |
||||
153 | 25131145 |
US |
||
Fatigue, Illness, Insomnia, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
154 | 25131228 |
US |
||
Cerebrovascular accident, Illness, |
||||
MEPOLIZUMAB, |
||||
155 | 25131482 |
US |
59 | 2 |
Knee arthroplasty, Nasopharyngitis, Illness, Arthralgia, Arthritis infective, |
||||
UPADACITINIB, |
||||
156 | 25131636 |
CA |
72 | 2 |
Illness, Viral infection, Product dose omission issue, |
||||
RITUXIMAB, RITUXIMAB, |
||||
157 | 25131697 |
US |
||
Rheumatoid arthritis, Illness, Blood glucose abnormal, COVID-19, |
||||
ASFOTASE ALFA, |
||||
158 | 25131828 |
US |
||
Pyrexia, Illness, |
||||
GALSULFASE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
159 | 25131911 |
US |
79 | 2 |
Surgery, Illness, Vocal cord disorder, Intervertebral disc protrusion, Speech disorder, |
||||
RISANKIZUMAB-RZAA, |
||||
160 | 25134196 |
65 | 2 | |
Illness, Lower limb fracture, |
||||
TOCILIZUMAB, |
||||
161 | 25134436 |
2 | ||
Illness, |
||||
LENALIDOMIDE, AMLODIPINE, LENALIDOMIDE, |
||||
162 | 25134586 |
71 | 2 | |
Illness, Therapy interrupted, |
||||
ABATACEPT, |
||||
163 | 25134672 |
61 | 2 | |
Illness, |
||||
ETANERCEPT, |
||||
164 | 25134791 |
62 | 2 | |
Therapy interrupted, Illness, |
||||
UPADACITINIB, |
||||
165 | 25120957 |
US |
||
Dyspnoea, Product dose omission issue, Illness, Tremor, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
166 | 25120972 |
US |
2 | |
Blood thyroid stimulating hormone abnormal, Chest pain, Insomnia, Blood thyroid stimulating hormone increased, Product blister packaging issue, Joint stiffness, Thyroid hormones decreased, Feeling abnormal, Gait inability, Illness, Condition aggravated, Electrolyte imbalance, Blood electrolytes increased, Joint swelling, Chromatopsia, Muscle disorder, |
||||
LEVOTHYROXINE SODIUM, |
||||
167 | 25121067 |
US |
2 | |
Drug tolerance decreased, Illness, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, OLMESARTAN MEDOXOMIL, FLUTICASONE PROPIONATE, RIVAROXABAN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ALBUTEROL SULFATE, NINTEDANIB, ALPRAZOLAM, SPIRONOLACTONE, MONTELUKAST SODIUM, MONTELUKAST, OXYGEN, 0XYGEN, TIOTROPIUM BROMIDE AND OLODATEROL, CETIRIZINE HYDROCHLORIDE, IPRATROPIUM BROMIDE, |
||||
168 | 25121237 |
US |
58 | 2 |
Dyspnoea, Illness, |
||||
DUPILUMAB, |
||||
169 | 25121322 |
US |
54 | 2 |
Illness, |
||||
RITUXIMAB, CELECOXIB, CYCLOBENZAPRINE, METHOCARBAMOL, METHOCARBAMOL TABLETS, GABAPENTIN, |
||||
170 | 25121442 |
GB |
70 | 2 |
Illness, Diarrhoea, Abdominal pain upper, |
||||
CELECOXIB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
171 | 25121749 |
US |
42 | 2 |
Product use issue, Transaminases increased, Illness, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, TOLVAPTAN, TOLVAPTAN, TOLVAPTAN, TOLVAPTAN, TOLVAPTAN, |
||||
172 | 25121769 |
US |
1 | |
Illness, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
173 | 25121858 |
US |
2 | |
Reproductive complication associated with device, Female sterilisation, Loss of consciousness, Device breakage, Foreign body in reproductive tract, Complication of device removal, Cyst, Hormone level abnormal, Alopecia, Rash, Illness, Emotional disorder, Pain, Abnormal uterine bleeding, Bacterial infection, Pelvic pain, Abdominal pain, |
||||
COPPER, |
||||
174 | 25121874 |
US |
61 | 2 |
Illness, |
||||
SEMAGLUTIDE, |
||||
175 | 25122266 |
US |
1 | |
Illness, |
||||
PIMAVANSERIN TARTRATE, FEXOFENADINE HYDROCHLORIDE, OIL, BIOTIN, HAIR, BUMETANIDE, CALCIUM, CARBIDOPA LEVODOPA, ENTACAPONE, FLUCONAZOLE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LOSARTAN POTASSIUM, LOSARTAN, MAGNESIUM, POLYETHYLENE GLYCOL 3350, NALOXONE HYDROCHLORIDE NASAL, NALOXONE HYDROCHLORIDE, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SEMAGLUTIDE, PRAMIPEXOLE, |
||||
176 | 25122490 |
US |
||
General physical health deterioration, Illness, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
177 | 25122686 |
GB |
||
Illness, Diarrhoea, Abdominal pain upper, |
||||
CELECOXIB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
178 | 25122782 |
GB |
||
Illness, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
179 | 25123157 |
US |
2 | |
Vertigo, Illness, Nausea, Vomiting, |
||||
TIRZEPATIDE, |
||||
180 | 25123181 |
US |
2 | 2 |
Illness, |
||||
DUPILUMAB, |
||||
181 | 25123189 |
US |
2 | |
Illness, Intentional dose omission, |
||||
182 | 25123294 |
US |
53 | 1 |
Peripheral swelling, Self-medication, Product dose omission issue, Pulmonary function test decreased, Illness, |
||||
EPINEPHRINE, ADRENALINUM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
183 | 25123447 |
US |
37 | 1 |
Illness, |
||||
ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, |
||||
184 | 25123520 |
US |
56 | 2 |
Illness, Dyspnoea, Pyrexia, Product dose omission issue, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, EPINEPHRINE, ADRENALINUM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, LEVOTHYROXINE SODIUM, BUDESONIDE, HYDROCHLOROTHIAZIDE, ALBUTEROL SULFATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALPRAZOLAM, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ALBUTEROL SULFATE, TIOTROPIUM BROMIDE INHALATION SPRAY, METHYLPREDNISOLONE, SERTRALINE HYDROCHLORIDE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, MELATONIN, GABAPENTIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, OXYGEN, 0XYGEN, MONTELUKAST SODIUM, MONTELUKAST, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, |
||||
185 | 25123562 |
US |
2 | |
Fatigue, Therapy interrupted, Illness, |
||||
UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ROFLUMILAST, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, GABAPENTIN, LACTULOSE, LANSOPRAZOLE, LORATADINE, LORATADINE ORAL, PREDNISOLONE ACETATE, BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, DIAZEPAM, LEVALBUTEROL TARTRATE, EPINEPHRINE, ADRENALINUM, BIMATOPROST, MORPHINE SULFATE, ALPRAZOLAM, TIZANIDINE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, ROFLUMILAST, DOXYCYCLINE, DOXYCYCLINE HYCLATE, FLUCONAZOLE, LEVALBUTEROL TARTRATE, MONTELUKAST SODIUM, MONTELUKAST, ALBUTEROL SULFATE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, CLINDAMYCIN HYDROCHLORIDE, LATANOPROST, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE, DENOSUMAB, |
||||
186 | 25123588 |
US |
63 | 2 |
Illness, Urticaria, Pruritus, Urticaria, Dyspnoea, Burning sensation, |
||||
EPINEPHRINE, ADRENALINUM, GABAPENTIN, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, GUAIFENESIN, MEDROXYPROGESTERONE ACETATE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, MUPIROCIN, MUPIROCIN CALCIUM, CLOBETASOL PROPIONATE, CONJUGATED ESTROGENS, ESTROGENS, CONJUGATED, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, LEVOTHYROXINE SODIUM, |
||||
187 | 25123711 |
US |
71 | 2 |
Pulmonary toxicity, Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth, Pneumonitis, Lung disorder, Illness, Product quality issue, |
||||
ADALIMUMAB, ADALIMUMAB, MELOXICAM, OXYBUTYNIN, ESOMEPRAZOLE MAGNESIUM, AMOXICILLIN, |
||||
188 | 25123720 |
US |
||
Gastrointestinal haemorrhage, Illness, Condition aggravated, Full blood count abnormal, Discontinued product administered, |
||||
OLAPARIB, |
||||
189 | 25123880 |
US |
78 | 2 |
Illness, Nasopharyngitis, Arthralgia, |
||||
TOFACITINIB, CALCIUM, DENOSUMAB, MAGNESIUM, |
||||
190 | 25123920 |
US |
77 | 2 |
Renal disorder, Illness, Nausea, Vomiting, |
||||
METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ACALABRUTINIB, CYANOCOBALAMIN, EVOLOCUMAB, LOPERAMIDE HYDROCHLORIDE, CALCIUM CARBONATE, SIMETHICONE, SIMETHICONE, GABAPENTIN, FAMOTIDINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, APIXABAN, CEPHALEXIN, BROMOCRIPTINE MESYLATE, ALLOPURINOL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
191 | 25124068 |
US |
2 | |
Illness, Asthma, |
||||
DUPILUMAB, |
||||
192 | 25124141 |
US |
88 | 2 |
Illness, |
||||
TAFAMIDIS MEGLUMINE, |
||||
193 | 25124348 |
US |
72 | 2 |
Dyspnoea, Oropharyngeal pain, Drug ineffective for unapproved indication, Nausea, Abdominal pain upper, Asthenia, Vomiting, Illness, Off label use, |
||||
RIMEGEPANT SULFATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
194 | 25124369 |
CA |
40 | 2 |
Illness, Influenza, |
||||
OFATUMUMAB, |
||||
195 | 25124400 |
CA |
2 | |
Diabetes mellitus, Fatigue, Illness, Injection site discomfort, Drug ineffective, Product dose omission issue, Off label use, |
||||
ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, |
||||
196 | 25124418 |
US |
||
Illness, |
||||
BENRALIZUMAB, |
||||
197 | 25124558 |
RO |
49 | |
Pancreatic carcinoma, Illness, |
||||
ANIFROLUMAB-FNIA, |
||||
198 | 25124573 |
US |
52 | 2 |
Illness, Nasopharyngitis, Cough, Pyrexia, Product dose omission issue, |
||||
DUPILUMAB, |
||||
199 | 25124592 |
CA |
74 | 1 |
Abdominal pain upper, Decreased appetite, Diarrhoea, Gastrointestinal sounds abnormal, Illness, Renal pain, |
||||
RITUXIMAB, |
||||
200 | 25124865 |
US |
1 | |
Hepatic vein thrombosis, Respiratory syncytial virus infection, Product availability issue, Illness, |
||||
BIMEKIZUMAB, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28